Cost-effectiveness analysis finds improved outcomes with a cancer board in breast cancer management, suggesting better resource use.
The treatment strategy developed by involving a BM cancer board is more cost-effective than that developed without involving such a board, justifying healthcare resource allocation for implementation of this board.
No takes yet. Share an insight, caveat, or question.
Yanagaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: